Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the complete cytogenetic response (CCyR ) rate at 12 months of nilotinib compared to imatinib in adult patients with Ph+ CML in CP who have a suboptimal cytogenetic response to imatinib.
Inclusion criteria
- Nilotinib will be evaluated in patients having showed a suboptimal cytogenetic response to imatinib